Creative Graphics built a ₹346 crore packaging group by FY26
Key highlights
- Creative Graphics reported ₹346 crore of consolidated revenue in FY26, compared with ₹68.3 crore from flexography only in FY22.
- Creative Graphics says pharma packaging became its larger revenue contributor just over three years after Wahren started production in 2023.
- Creative Graphics reports 44,000 MTPA of pharma capacity: 20,000 MT of Alu Alu, 12,000 MT of PVC/PVDC and 12,000 MT of tandem extrusion capacity.
- Creative Graphics has nine flexography plants, with eight in India and one installed in Oman during FY26.
powered by IRIS

Creative Graphics Solutions India Limited built a ₹346 crore consolidated packaging group by FY26, up from ₹68.3 crore of flexography-only revenue in FY22, after its pharma subsidiary began production in 2023 and pharma packaging became the larger revenue contributor in just over three years.
Know Creative Graphics Solutions India inside out
Results, valuation, peers and who's buying, in one view.
How did Creative Graphics become a two-business packaging group?
Creative Graphics became a two-business group by retaining flexography and adding pharmaceutical packaging through its 100% subsidiary, Wahren India Private Limited. The flexo plate business began in the early 2000s, while the company was incorporated in 2014 and expanded through Vasai in 2014, Chennai in 2017, Baddi and Hyderabad in 2018, Ahmedabad in 2021, and Pune in 2022. Wahren started production in 2023, adding a pharma packaging operation to the established flexography platform.
The reported revenue series shows that the operating scope changed after FY23. Flexography-only revenue increased from ₹68.3 crore in FY22 to ₹90.1 crore in FY23; revenue reported with pharma packaging was ₹131.6 crore in FY24, ₹251.1 crore in FY25 and ₹346 crore in FY26. Creative Graphics describes this as fivefold growth in four years, while consolidated profit after tax, or PAT, rose from ₹4.7 crore in FY22 to ₹18.8 crore in FY26.
Creative Graphics separately reported ₹155 crore of FY26 revenue for its standalone business, up 38.9%. However, the presentation says standalone revenue includes sales to Wahren that are eliminated on consolidation. The ₹155 crore figure therefore cannot be used to calculate Wahren's external revenue or the precise contribution of either business to the ₹346 crore consolidated total.
What does Creative Graphics sell through its two businesses?
Creative Graphics sells photopolymer printing plates, design and prepress services in flexography, and primary pharmaceutical packaging through Wahren. The flexography business prepares brand artwork for printing on film, foil, paper and board, serving fast-moving consumer goods, food, pharma and industrial packaging customers. CG Premedia, the group’s design and prepress operation, was launched in 2021.
Wahren produces high-barrier packaging for tablets and capsules, including cold-formed Alu Alu foil, blister lidding foils, polyvinyl chloride and polyvinylidene chloride, or PVC/PVDC, films, and extrusion laminates. Creative Graphics says the portfolio expansion under execution also includes sachets, strip foils, blister foils and child-resistant formats. These additions are stated plans, rather than disclosed sales categories with reported revenue.
The disclosed pharma capacity is 44,000 metric tonnes per annum, or MTPA. An Italian Bobst EXPERTCOAT 1000 line takes Alu Alu capacity to 20,000 metric tonnes, or MT; a German PVC/PVDC coating line has 12,000 MT capacity; and a South Korean tandem extrusion line has 12,000 MT capacity. An Indian heat-seal coating machine supports lidding foil production, but the presentation does not state a separate capacity figure for that machine.
Where does Creative Graphics operate and what supports the network?
Creative Graphics has nine flexography plants across India and Oman, comprising eight in India and one installed in Oman in FY26. The company says the Oman facility had not yet started commercial operations when the presentation was prepared. Its Kolkata operation is a joint venture and is not included in the reported nine-plant count.
The Indian network covers eight cities and seven states, with listed facilities in Noida, Vasai, Chennai, Baddi, Hyderabad, Ahmedabad, Pune and Bengaluru. Bengaluru opened in August 2025, while the Oman plant was installed in FY26. Creative Graphics says it serves more than 12 countries and has more than 4,350 active clients, comprising more than 4,000 flexography customers and more than 350 pharma packaging customers.
Creative Graphics reported 497 employees on its payroll at 31 March 2026. The combination of nine flexography plants and 44,000 MTPA of pharma capacity gives the group two separate manufacturing platforms: a geographically distributed plate network and a product-based pharma packaging operation. The presentation does not disclose capacity utilisation for either platform.
Got a follow-up? Ask IRIS
Why did Creative Graphics enter pharmaceutical packaging?
Creative Graphics entered pharma packaging because management identified demand for compliance-ready primary packaging and believed its existing pharma customer relationships could shorten Wahren’s customer-acquisition cycle. The company says its flexo plates already served pharma companies before Wahren started production in 2023. It also cites precision manufacturing, quality systems and compliance as capabilities supporting the move.
Management’s stated commercial rationale is that pharma packaging has moderate percentage margins but higher volumes, which can raise absolute contribution and asset turnover as utilisation increases. This is an operating rationale rather than a reported result: the presentation does not provide product-line margins, utilisation rates or separate profitability for Wahren. It does state that pharma packaging had become the larger revenue contributor by FY26.
Creative Graphics also describes the entry as capital-efficient because the PVC/PVDC and tandem lines were acquired through a National Company Law Tribunal, or NCLT, process at about 10% of estimated replacement cost. Each line has 12,000 MT capacity, complementing the 20,000 MT Alu Alu line. The presentation does not disclose the acquisition price or the estimated replacement cost in rupees.
How is Creative Graphics expanding after the first transition?
Creative Graphics is expanding flexography by geography and pharma packaging by product depth. Bengaluru is operational after opening in August 2025, while the Oman manufacturing footprint was installed in FY26 as an entry point to the Middle East and Africa. The company says the aim is wider domestic and international reach, although commercial operations at Oman were still pending.
In pharma packaging, Creative Graphics plans to broaden the product range around Alu Alu foil, PVC/PVDC films and extrusion laminates, followed by sachets, strip foils, blister foils and child-resistant formats. Management says the objective is to serve clients across primary packaging requirements through one relationship. The presentation identifies the direction of expansion but gives no dated sales or revenue target for the additional product categories.
The transformation therefore does not represent a replacement of flexography by pharma packaging. Creative Graphics says both businesses are expanding together, with flexography extending into new regions and pharma adding product categories. The reported FY26 combination of ₹155 crore standalone revenue and ₹346 crore consolidated revenue illustrates the group structure, but consolidation adjustments prevent a direct comparison of external sales by the two businesses.
Conclusion
Creative Graphics has changed from a flexo plate and prepress business with ₹68.3 crore of FY22 revenue into a packaging group reporting ₹346 crore of consolidated FY26 revenue. The change was built on Wahren’s 44,000 MTPA pharma packaging platform while the flexography network expanded to nine plants across India and Oman.
The next measures to watch are commercial commencement at the Oman plant installed in FY26 and execution of the planned pharma portfolio additions beyond Alu Alu foil, PVC/PVDC films and extrusion laminates. The presentation identifies pharma packaging as the larger revenue contributor by FY26, but does not disclose an entity-level external-revenue split or utilisation rates for the new capacity.


